---
title: "CLARITEV CORPORATION C/WTS 08/10/2025(TO PUR COM) | 10-Q: FY2025 Q1 Revenue: USD 231.33 M"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/239558801.md"
datetime: "2025-05-09T11:43:44.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/239558801.md)
  - [en](https://longbridge.com/en/news/239558801.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/239558801.md)
generator: "portal-rs"
---

# CLARITEV CORPORATION C/WTS 08/10/2025(TO PUR COM) | 10-Q: FY2025 Q1 Revenue: USD 231.33 M

Revenue: As of FY2025 Q1, the actual value is USD 231.33 M.

EPS: As of FY2025 Q1, the actual value is USD -4.38.

EBIT: As of FY2025 Q1, the actual value is USD 112.35 M.

### Segment Revenue

-   **Network-Based Services**: Revenue increased by $0.7 million, or 1.6%, to $46.9 million for the three months ended March 31, 2025, compared to $46.2 million for the same period in 2024.
-   **Analytics-Based Services**: Revenue decreased by $6.7 million, or 4.2%, to $153.4 million for the three months ended March 31, 2025, compared to $160.1 million for the same period in 2024.
-   **Payment and Revenue Integrity Services**: Revenue increased by $2.7 million, or 9.7%, to $31.0 million for the three months ended March 31, 2025, compared to $28.3 million for the same period in 2024.

### Operational Metrics

-   **Operating Income**: The company reported an operating income of $9.7 million for the three months ended March 31, 2025, compared to an operating loss of $486.4 million for the same period in 2024.
-   **Net Loss**: The net loss was $71.3 million for the three months ended March 31, 2025, compared to a net loss of $539.7 million for the same period in 2024.

### Cash Flow

-   **Net Cash Used in Operating Activities**: The company reported net cash used in operating activities of $30.1 million for the three months ended March 31, 2025, compared to net cash provided by operating activities of $49.7 million for the same period in 2024.
-   **Net Cash Used in Investing Activities**: The company reported net cash used in investing activities of $38.9 million for the three months ended March 31, 2025, compared to $30.5 million for the same period in 2024.
-   **Net Cash Provided by Financing Activities**: The company reported net cash provided by financing activities of $73.2 million for the three months ended March 31, 2025, compared to net cash used in financing activities of $31.5 million for the same period in 2024.

### Future Outlook and Strategy

-   **Core Business Focus**: The company plans to continue its focus on data-driven cost management solutions, aiming to enhance transparency and promote fairness in the U.S. healthcare industry. The company is also focused on expanding its service lines, including Analytics-Based Services and Payment and Revenue Integrity Services, to drive future growth.
-   **Non-Core Business**: The company has entered into a partnership agreement with ECHO Health, Inc. to add payment processing of healthcare provider claims, which is expected to complement its existing service offerings.

### Related Stocks

- [MPLNW.US](https://longbridge.com/en/quote/MPLNW.US.md)

## Related News & Research

- [Berkshire Hathaway Just Sold 3 Bank Stocks. Here’s Why Investors Should Take Notice](https://longbridge.com/en/news/297771081.md)
- [Next Phase Of AI–Elon Musk’s 1 Billion Robots](https://longbridge.com/en/news/297821554.md)
- [HPE Earnings Prediction Market Preview: Will Antonio Neri Say ‘Self Driving’ Again?](https://longbridge.com/en/news/297812809.md)
- [HPE follows in Dell's footsteps as it rides the AI server boom to a big earnings beat](https://longbridge.com/en/news/297824285.md)
- [Dan Ives Says M&A Is the ‘Missing Piece’ for Apple in AI Arms Race — New CEO John Ternus Could Finally Shake Up Tim Cook’s Playbook](https://longbridge.com/en/news/297774464.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**